Clinical Trial Update: Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol [Phase 2]

View source ↗

Summary

A Phase 2 pharmacodynamic study evaluating a cardiovascular polypill’s effect on LDL cholesterol has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Cardiovascular Polypill

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Elevated LDL Cholesterol | Phase 2 | Status: TERMINATED